Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation

NCT03605953 · clinicaltrials.gov ↗
UNKNOWN
Status
134
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Central Hospital, Nancy, France